US approves Johnson & Johnson COVID-19 vaccine: What are the advantages of the vaccine?

US approves Johnson & Johnson COVID-19 vaccine: What are the advantages of the vaccine?

Johnson & Johnson’s vaccine’s efficacy rate came out to be 72% in the clinical trial site in the US. Johnson & Johnson’s COVID-19 vaccine: Johnson & Johnson’s single-shot vaccination against the novel coronavirus SARS-CoV-2 has been approved by the US for emergency use. This means that in the coming week, the rollout of millions of … Read more

Non-Covid deaths increase in US compared to last year, finds study

Non-Covid deaths increase in US compared to last year, finds study

Death rate not related to Covid-19 in the US has outpaced the mortality rates recorded in 2019. (REpresentative Image, AP Photo) The United States has witnessed a significantly higher number of deaths between March and May this year as compared to the same period last year and not all the additional deaths are caused by … Read more

Coronavirus in India: Despite lowering daily cases, Delhi, Kerala displaying reverse trends

Coronavirus in India: Despite lowering daily cases, Delhi, Kerala displaying reverse trends

Kerala would be the state to be most concerned about, if it weren’t for Delhi. Coronavirus in India: While the coronavirus cases in the country are on a decline, some states have been displaying counter-trends. On Wednesday, Kerala reported about 7,000 new cases and became the sixth state to have crossed the 5 lakh-cases milestone. … Read more

COVID-19: After Hong Kong and Europe, US reports first case of virus reinfection

COVID-19: After Hong Kong and Europe, US reports first case of virus reinfection

The findings have not yet been published or reviewed by other scientists. Nevada officials are reporting what may be the first documented case of coronavirus reinfection in the United States, following similar reports earlier this week from Hong Kong and Europe. A 25-year-old Reno man with mild COVID-19 symptoms initially was found to have the … Read more